Skip to main content
. 2019 Aug 28;317(5):G640–G650. doi: 10.1152/ajpgi.00205.2019

Fig. 3.

Fig. 3.

Afferent modulation and novel analgesics for pain in lower functional gastrointestinal disorders. CFTR, cystic fibrosis transmembrane regulator; GI, gastrointestinal; NHE3, Na+/H+ exchanger 3; PDE3, phosphodiesterase type 3; TRV130, oliceridine; µ-OR, µ-opioid receptor. [Reproduced with permission from Waldman and Camilleri (84) and Camilleri (7).]